$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What important information is contained in the detailed instructions for Besudil/Elaco
2026-02-01 22:25:32
Check Details
Introduction to the launch time of Brivaracetam in China
2026-02-01 22:25:32
Check Details
Analysis of whether ruxolitinib cream (Opzelura) is included in medical insurance and reimbursement for patients
2026-02-01 22:25:32
Check Details
Jisandai (Epclusa) latest price and market purchase reference in 2025
2026-02-01 22:25:32
Check Details
Analysis of efficacy and clinical trial data of sunitinib (Sutent) in the treatment of lung cancer
2026-02-01 22:25:32
Check Details
What are the adverse reactions of Tazetostat (Davico) and analysis of treatment methods
2026-02-01 22:25:32
Check Details
How long do you need to continue taking ceritinib/ceritinib (Zanda) and the reference course of treatment?
2026-02-01 22:25:32
Check Details
Regular purchasing channels for Belzutifan and patient medication safety reminders
2026-02-01 22:25:32
Check Details
Can dabrafenib (Tefila) be used to treat lung adenocarcinoma and related research data
2026-02-01 22:25:32
Check Details
Is Axitinib an imported drug? What are its import channels and domestic sales price?
2026-02-01 22:25:32
Check Details
The types of targets targeted by Trametinib (Megenin) and the scientific basis for treating tumors
2026-02-01 22:25:32
Check Details
The mechanism of action of avatrombopag (Sucoxin) and the scientific principle of platelet elevation
2026-02-01 22:25:32
Check Details
1
2
...
2070
2071
2072
2073
2074
2075
2076
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
2
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
3
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
4
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
5
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
6
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
7
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
8
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
9
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
10
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
11
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
12
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older